$ZYME: Zymeworks Submits Investigational New Drug (IND) Application for …

Date: Saturday, December 8th, 2018

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: VANCOUVER, Canada–(BUSINESS WIRE)–Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional …

Full article address: https://www.businesswire.com/news/home/20181208005005/en/Zymeworks-Submits-Investigational-New-Drug-IND-Application

Related News:

$ZYME: Zymeworks Reports 2018 Year-End Financial Results

$ZYME: Zymeworks to Present at Barclays 2019 Global Healthcare Conference

$ZYME: Zymeworks Reports Second Investigational New Drug (IND …

$ZYME: Zymeworks outlines 2019 priorities

$ZYME: Zymeworks Highlights 2018 Achievements and Announces 2019 …

$ZYME $FISI: Here is What Hedge Funds Think About Zymeworks Inc. (ZYME)

$PACQ $ZYME $MUI: Is Vishay Precision Group Inc (VPG) A Good Stock To Buy?

$PACQ $ZYME $MUI: Is Pure Acquisition Corp. (PACQ) A Good Stock To Buy?

$ZYME: Zymeworks Inc.: A Blockbuster In The Making

$ZYME: Zymeworks presents IND-enabling data of ZW49 at the San Antonio …

$BGNE $ZYME: Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody …

Latest News:

$VIX: From Lyft to Airbnb, new round of IPOs is no market top: Nick Colas

$ASND: Ascendis Pharma Announces Phase 3 heiGHt Trial Demonstrated …

$MKC: McCormick Earnings: What to Watch

$DWDP: Is DowDuPont a Buy?

$T $VIA: Viacom and AT&T Negotiate to Avert Major Programming Blackout

$MGM $CZR $VICI: How Wynn Resorts Could Free Up Billions in Cash

$PYX $RKDA: CBD is booming. But US farmers struggle to keep up with demand for industrial hemp

$GE: 3 Stocks Looking to Benefit From GE’s Misfortunes

$LEVI: Before the Levi’s IPO, there was the 1985 buyout led by iconoclastic S.F. investor Warren Hellman

$TLRY $CGC: 1 Figure That Guarantees a Canadian Marijuana Oversupply Is …

$AAPL $GS: Steve Jobs was trying to revolutionize TV almost a decade ago — now we’ll find out Apple’s plan